title: Alzheimer's disease biomarkers: correspondence between human studies and animal models.
abstract: Alzheimer's disease (AD) represents an escalating global threat as life expectancy and disease prevalence continue to increase. There is a considerable need for earlier diagnoses to improve clinical outcomes. Fluid biomarkers measured from cerebrospinal fluid (CSF) and blood, or imaging biomarkers have considerable potential to assist in the diagnosis and management of AD. An additional important utility of biomarkers is in novel therapeutic development and clinical trials to assess efficacy and side effects of therapeutic interventions. Because many biomarkers are initially examined in animal models, the extent to which markers translate from animals to humans is an important issue. The current review highlights many existing and pipeline biomarker approaches, focusing on the degree of correspondence between AD patients and animal models. The review also highlights the need for greater translational correspondence between human and animal biomarkers.
authors: Behavioral Neuroscience Laboratory, University of Nevada, Las Vegas, NV, USA.
authors: Jonathan J
authors: JJ
authors: Sabbagh
authors: Jefferson W
authors: JW
authors: Kinney
authors: Jeffrey L
authors: JL
authors: Cummings
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D042241:Early Diagnosis; D004569:Electroencephalography; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D049268:Positron-Emission Tomography
chemical_list: D015415:Biomarkers